Moody Lynn & Lieberson, LLC Eli Lilly & CO Transaction History

Moody Lynn & Lieberson, LLC

$1.54 Billion
Q3 2024

A detailed history of Moody Lynn & Lieberson, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Moody Lynn & Lieberson, LLC holds 89,585 shares of LLY stock, worth $71.1 Million. This represents 5.14% of its overall portfolio holdings.

Number of Shares

89,585

Previous 91,425 2.01%

Holding current value

$71.1 Million

Previous $82.8 Million 4.12%

% of portfolio

5.14%

Previous 5.61%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$772.14 - $960.02 $1.42 Million - $1.77 Million	-1,840 Reduced 2.01%	89,585 $79.4 Million
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $179,042 - $224,532	247 Added 0.27%	91,425 $82.8 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $176,475 - $236,099	298 Added 0.33%	91,178 $70.9 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $89,807 - $105,871	171 Added 0.19%	90,880 $53 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $3.39 Million - $4.68 Million	-7,807 Reduced 7.92%	90,709 $48.7 Million
Q2 2023 Jul 27, 2023	BUY	$350.74 - $468.98 $58,222 - $77,850	166 Added 0.17%	98,516 $46.2 Million
Q1 2023 May 02, 2023	SELL	$310.63 - $364.82 $1.21 Million - $1.42 Million	-3,882 Reduced 3.8%	98,350 $33.8 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $688,760 - $802,543	2,142 Added 2.14%	102,232 $37.4 Million
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $1.73 Million - $1.97 Million	-5,826 Reduced 5.5%	100,090 $32.4 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $2.65 Million - $3.11 Million	-9,490 Reduced 8.22%	105,916 $34.3 Million
Q1 2022 Apr 27, 2022	SELL	$234.69 - $291.66 $1.19 Million - $1.48 Million	-5,070 Reduced 4.21%	115,406 $33 Million
Q4 2021 Jan 26, 2022	SELL	$224.85 - $279.04 $45,644 - $56,645	-203 Reduced 0.17%	120,476 $33.3 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $155,341 - $191,169	-701 Reduced 0.58%	120,679 $27.9 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $4.35 Million - $5.62 Million	24,071 Added 24.74%	121,380 $27.9 Million
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $151,174 - $195,702	-920 Reduced 0.94%	97,309 $18.2 Million
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $1.79 Million - $2.37 Million	13,739 Added 16.26%	98,229 $16.6 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $1.13 Million - $1.31 Million	-7,742 Reduced 8.39%	84,490 $12.5 Million
Q2 2020 Jul 24, 2020	SELL	$136.42 - $164.18 $2.87 Million - $3.45 Million	-21,041 Reduced 18.58%	92,232 $15.1 Million
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $13.5 Million - $16.7 Million	113,273 New	113,273 $15.7 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $4.93 Million - $5.8 Million	-44,291 Closed	0 $0
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $4.69 Million - $5.25 Million	44,291 New	44,291 $5.13 Million
Q1 2018 Apr 27, 2018	SELL	$74.21 - $87.6 $856,160 - $1.01 Million	-11,537 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $12,454 - $13,359	-152 Reduced 1.3%	11,537 $993,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $900,871 - $999,877	11,689	11,689 $1 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Lynn & Lieberson, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Lynn & Lieberson, LLC with notifications on news.

Account

Moody Lynn & Lieberson, LLC Eli Lilly & CO Transaction History